Cytochrome c oxidase (CcO) is a multimetallic enzyme that carries out the reduction of O 2 to H2O and is essential to respiration, providing the energy that powers all aerobic organisms by generating heat and forming ATP. The oxygen-binding heme a 3 should be subject to fatal inhibition by chemicals that could compete with O 2 binding. Near the CcO active site is another enzyme, NO synthase, which produces the gaseous hormone NO. NO can strongly bind to heme a 3, thus inhibiting respiration. However, this disaster does not occur. Using functional models for the CcO active site, we show how NO inhibition is avoided; in fact, it is found that NO can protect the respiratory enzyme from other inhibitors such as cyanide, a classic poison.
I
n this article we answer an important question: why is the active site of the respiratory enzyme cytochrome c oxidase (CcO) not severely inhibited by the diffusing hormone NO, produced by a neighboring NO synthase (NOS)? Moreover, we demonstrate that NO should protect CcO from other inhibitors.
CcO is a multicomponent membrane protein that catalyzes the 4e Ϫ reduction of O 2 to H 2 O in all eukaryotes (1). The energy released in this process is used to produce a proton gradient across the membrane, which provides the driving force for ATP synthesis. The active site of CcO contains a bimetallic center comprising an iron porphyrin heme a 3 and a tris-histidine-coordinated Cu (Cu B ) in the distal pocket ( Fig. 1) (2, 3) . During catalytic turnover, the Fe II /Cu I center reduces O 2 , and the resulting oxidized site is reduced via electron transfer from two electron donors, heme a and Cu A , regenerating the Fe II /Cu I site. CcO is strongly inhibited by high levels of nitric oxide (NO) (K I ϭ 0.27 M), carbon monoxide (CO) (K I ϭ 0.32 M), and cyanide (CN Ϫ ) (K I ϭ 0.2 M) (4) . NO is produced continuously in the mitochondrial membrane adjacent to CcO by mitochondrial NOS (5, 6) . Apart from car exhaust and cigarette smoke, CN Ϫ is produced naturally in the human body as a metabolic by-product of cyanogenic glycosides that are present in bitter almonds, apple seeds, raw yucca, and cassava roots (7) . CO is produced in cells as a by-product of heme degradation (8) . Any sudden increase in the flux of these inhibitors leads to a surge of partially reduced oxygen species in the cell, which eventually leads to cell death (9) . NO has a high equilibrium binding constant (K d Ͻ 10 Ϫ9 M) and a fast second-order kinetic rate constant (k on ϭ Ϸ10 8 M Ϫ1 ⅐s Ϫ1 ) for reduced ferrous porphyrin active sites, including the reduced heme a 3 site of CcO (10, 11) . Because of a constant flux of NO at the CcO active site ([O 2 ]/[NO] ϭ 1,000 in mitochondria), there must be a pathway to avoid inhibition. Inhibition of CcO by NO has been reported to be reversible in the presence of O 2 ; that is, after the initial inhibition by NO, the O 2 -reducing activity of CcO is slowly regained in the presence of O 2 (11) (12) (13) . From optical studies of the interaction of oxymyoglobin (Mb-O 2 ) with NO-bound CcO, Sarti et al. (14, 15) proposed a mechanism that entails dissociation of bound NO from the heme a 3 site. However, this proposal presents a dilemma, because dissociation of NO from heme a 3 has a first-order rate of k off ϭ 0.004 s Ϫ1 , which is orders of magnitude slower than the rate necessary for normal CcO turnover. Pearce et al. (16) (17) . A classic inhibitor of CcO, CN Ϫ binds tightly to the fully oxidized site (K d ϭ 10 Ϫ6 M), resulting in the formation of a low-spin heme a 3 center (18) . This binding shifts the reduction potential (E°) of heme a 3 to ϩ150 mV (E°ϭ ϩ350 mV resting), which should jeopardize the reduction of the fully oxidized Fe III /Cu II form to the catalytically active Fe II /Cu I form by the adjacent heme a center (E°ϭ 250-300 mV), which could also inhibit the enzyme turnover (19) . The common antidote for CN Ϫ poisoning is to administer organic nitrites [e.g., amyl nitrite (AmN)], thiosulfate, and plentiful oxygen. In this article we use a functional synthetic model complex of CcO in its monometallic Fe-only form (1) or in its functional bimetallic Fe/Cu form (2) to study the interaction of NO with these inhibitors and suggest a mechanism of recovery from each inhibitor (20) (21) (22) .
Results and Discussion
The mononitrosyl complexes 1-NO and 2-NO were prepared before studying reactivity with O 2 and/or O 2 Ϫ . These NO complexes were generated by addition of 1 eq of NO (Scheme 1) to their respective precursors. Their absorption spectra show significant shifts in the absorption bands: 428 nm (Soret) and 536 nm to 425 nm (Soret) and 548 nm, respectively (Fig. 2) . The EPR of both 1-NO and 2-NO ( Fig. 3 ) is characteristic of low-spin six-coordinate S ϭ 1/2 iron-nitrosyl species with g z ϭ 2.078, g y ϭ 2.015, and g x ϭ 1.97. The multiple 14 N superhyperfine in the A y (N Imz ϭ 6 cm Ϫ1 , N NO ϭ 22 cm Ϫ1 ) and its perturbation by isotopically enriched 15 NO (N Imz ϭ 6 cm Ϫ1 , N NO ϭ 31 cm Ϫ1 ) are similar to data previously reported for CcO's active site and six-coordinate iron nitrosyl with imidazole axial ligands [supporting information (SI) Fig. S1 ] (23, 24) . Addition of excess O 2 to 1-NO, even after prolonged exposure, does not result in any change, neither in the UV-visible (UV-Vis) nor in the EPR spectra (1-NO-O 2 ; Figs. 2 A and 3A). However, with 2-NO, addition of O 2 shifts of the absorption maxima to 429 and 539 nm (Fig. 2B) , which is similar to that of the ferrous form. Simultaneous EPR experiments show loss of the characteristic ironnitrosyl S ϭ 1/2 signal and development of another S ϭ 1/2 signal, which is characteristic of a type 2 Cu 2ϩ species (g ʈ ϭ 2.40, g Ќ ϭ Adding CO to a solution of the unsubstituted ferrous-heme 1 leads to sharpening of the Soret and a small red shift of the band at 536 nm, which is indicative of the ferrous carbonyl complex 1-CO ( max ϭ 427 nm, 538 nm; Fig. 4A , red). Adding 10 eq of CN Ϫ to 1 produces a red shift in both the Soret and the Q band, suggesting formation of a CN Ϫ complex 1-CN ( max ϭ 433 nm, 541 nm; Fig. 4A, blue) . Both of these molecules are either produced in the human body or present in our diet or environment, and they are known to be potent inhibitors of CcO. We have observed that both CO and CN Ϫ are replaced when equimolar NO ( max ϭ 425 nm, 548 nm; Fig. 4A , green) is added to a solution of 1-CN (Fig. 4A , blue) or 1-CO (Fig. 4A, red) (the substitution of CO by NO is much slower than that of CN Ϫ ). This result is further supported by the EPR spectrum of 1-CN-NO, which shows the characteristic S ϭ 1/2 iron-nitrosyl signal Ϸ3,200-3,600 G (Fig. 3A) after adding NO to the diamagnetic 1-CN species (Fig. 4B, green) . Parallel experiments were also performed with the active site of myoglobin. The absorption spectrum of Mb-CO has a Soret at 423 nm and Q bands at 544 and 582 nm that are shifted to 424, 551, and 582 nm, respectively, after adding NO, indicating displacement of CO to form the NO complex (26, 27) .
AmN is commonly used as an immediate treatment for accidental exposure to CN. When AmN is added to 2-CN (prepared by adding 10 eq of CN Ϫ to 2), an EPR spectrum is obtained (2-CNAmN; Fig. 4B, red) , which suggests a mixture of an oxidized Cu 2ϩ (indicated by the four-line hyperfine) and S ϭ 1/2 iron-nitrosyl species (indicated by the feature at 3,400 G). The total spin integration against a Cu 2ϩ standard shows the presence of two paramagnetic species in 2-CN-AmN. In contrast, no reaction was observed between AmN and copper free 1. We propose that AmN is reduced to amyl alkoxide and NO by the reduced Cu B , which becomes oxidized to Cu 2ϩ (Scheme 2). This NO generated in situ from AmN should replace the CN Ϫ , forming an iron-nitrosyl species at the heme a 3 site. This hypothesis was also evaluated by adding AmN to 2-CO (Fig. S3) . CN Ϫ is known to bind the oxidized Fe III form with a much higher affinity than to Fe II . In CcO, CN Ϫ binding shifts the reduction potential of the heme a 3 site by Ϫ200 mV (i.e., from ϩ350 to ϩ150 mV against a normal hydrogen electrode). At this potential the heme a 3 site could not be reduced by heme a, which has a reduction potential of only ϩ250 mV and is unchanged by CN Ϫ binding to heme a 3 (19) . This Ϫ200 mV decrease in reduction potential of heme a 3 should inhibit turnover of CcO. , which reacts with the iron-nitrosyl complex, possibly via a peroxynitrite intermediate, regenerating a ferrous heme a 3 site ready for turnover. Given the high binding constant of NO with heme a 3 and generation of NO by NOS adjacent to the mitochondria, we propose that this reaction recurs repeatedly during the normal turnover of CcO and plays a regulatory role in the functioning of CcO. NO also may be an active component in the defense of CcO against inhibitors such as CN Ϫ and CO. Because of its extremely high binding affinity for reduced heme a 3 , NO can replace either of these ligands, forming a stable ferrous nitrosyl complex, which could then be oxidized by O 2 Ϫ generated in situ, thereby regenerating the active enzyme. This in situ generation of O 2 Ϫ should provide also a defense against inhibitors that target the oxidized heme a 3 site (anionic ligands such as CN Ϫ , N 3 Ϫ , etc.) by reducing the oxidized site to the corresponding ferrous forms, which have much higher NO affinities. Indeed, an increase of O 2 Ϫ concentration has been observed in CcO during turnover when the heme a 3 site is inhibited by ligand binding (28) . Thus, a symbiotic interaction between a potent inhibitor (NO) and a reactive oxygen species by-product (O 2 Ϫ ) should protect CcO from external inhibitors. While NO defends the reduced site, O 2 Ϫ defends the oxidized site.
Materials and Methods
All chemical manipulations were carried out under N2 atmosphere unless mentioned otherwise. The synthesis of 1 and 2 has been reported previously (29) . These are generally synthesized as the Fe II and Fe II /Cu I forms, which are oxidized with stoichiometric amounts of ferrocenium tetrafluoroborate as and when mentioned. KO 2 and [18]crown6 were purchased from Aldrich Chemicals and used without further purification. High-purity NO was purchased from Praxair and was further purified by bubbling it twice through 4 M KOH and H 2O under N 2 atmosphere. The solubility of NO in acetonitrile was taken to be 14 mM as reported (30) . AmN was purchased from Aldrich and passed through a column of basic alumina before used to get rid of any amyl alcohol and nitrogen dioxide impurity that may have been present. For the NO ϩ O 2 reactions, 1 eq of NO was added, and the formation of the nitrosyl species was confirmed by UV-Vis and EPR spectroscopy. To the same sample, excess O 2 gas or 1 eq of superoxide was added and monitored by UV-Vis and EPR spectroscopy.
The CO samples were prepared by the addition to CO gas to the reduced complexes in a cuvette or EPR tube. The formation of the CO complexes was confirmed by UV-Vis spectroscopy. NO (soln) or AmN was then added to them.
CN Ϫ complexes were prepared by adding N,N,N,N-tetrabutylammonium cyanide to reduced or oxidized samples. The formation of the CN complexes was confirmed by UV-Vis and IR spectroscopy. NO (soln) or AmN was then added to them.
EPR spectra were obtained by using a Bruker EMX spectrometer, ER 041 XG microwave bridge, and ER 4102ST cavity. All X-band EPR samples were run at 77 K in a liquid nitrogen finger Dewar. A Cu standard (1.0 mM CuSO 4⅐5H2O with 2 mM HCl and 2 M NaClO 4) was used for spin quantitation of the EPR spectra. EPR data of the ferrous end product was obtained at liquid He temperature (4 K).
The UV-Vis spectra were collected by using a Hewlett-Packard apparatus 8452 glass cuvette (3-ml capacity) sealed with a 14/24 septum (solvent: dimethylformamide/dichloromethane; concentration in porphyrin: 1 ϫ 10 Ϫ5 M).
